20
Participants
Start Date
April 30, 2004
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Capecitabine
825 mg/m\^2 orally twice a day (BID), Mon-Fri during weeks 1, 2, 4, and 5.
Oxaliplatin
50 mg/m\^2 by vein (IV) over 2 hours on days 1, 8, 22, and 29.
Radiation Therapy (XRT)
Undergo radiotherapy\* once daily on days 1-3, 6-10, 13-17, 20-24, 27-31, 34-38, and 41-42. \*Patients with T3-4 lesions undergo radiotherapy once daily on days 43 and 44.
M. D. Anderson Cancer Center at University of Texas, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER